The global Duchenne muscular dystrophy (DMD) market is valued approximately at USD 1.38 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.7% over the forecast period ...

As it gears up to submit an approval application next year, Wave Life Sciences has presented fresh phase 2 data showing its ...

Sarepta Therapeutics has followed through on its promise to file for accelerated approval of its gene therapy SRP-9001 for Duchenne muscular dystrophy ... measures of physical ability, although ...

Rachel Kondo, creator and head writer of the hit series Shogun, has never shied away from confronting life’s most difficult ...

Your muscles get tired due to repeated use, lactic acid buildup, dehydration, poor nutrition, underlying health conditions, ...

2 In the Q+A interview below, Craig McDonald, MD, chair, Department of Physical Medicine ... to-treat-duchenne-muscular-dystrophy 2. Solid Biosciences Reports Positive Initial Clinical Data from ...

Delandistrogene moxeparvovec, a gene therapy approved for the treatment of Duchenne muscular dystrophy (DMD), was found ...

An 8-year-old northern Minnesota boy is one of the first in the country to receive a specific type of gene therapy treatment.

New Gene Therapy Approach Shows Promise for Duchenne Muscular Dystrophy July 24, 2024 — Researchers have made a significant breakthrough in developing a new gene therapy approach that restores ...

An 8-year-old northern Minnesota boy is one of the first in the country to receive a specific type of gene therapy treatment. Colton Belluzzo was diagnosed with a form of muscular dystrophy when ...

Duchenne muscular dystrophy (DMD) is a disorder that causes ... On the other hand, loss of muscle strength and mobility can lead to reduced physical activity. This can decrease the number of ...